Skip to main content
SpringerLink
Log in

Clinical Outcome and Management of Ureteral Obstruction Secondary to Gastric Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The clinical outcome of ureteral obstruction secondary to gastric cancer remains unclear. The present study was designed to evaluate the clinical outcome and predictive factors of survival in patients with ureteral obstruction secondary to gastric cancer.

Methods

Twenty-five consecutive patients with ureteral obstruction secondary to gastric cancer between January 1998 and December 2007 were retrospectively analyzed. All patients had hydronephrosis; 13 patients had bilateral hydronephrosis, and 12 patients had unilateral hydronephrosis.

Results

Ten patients presented with pain, 3 patients with urinary tract infection, and 2 patients with acute renal failure. Seven (58%) of 12 patients with unilateral ureteral obstruction experienced progression to bilateral ureteral obstruction during the follow-up period. Eighteen patients (61%) were eventually managed with urinary diversion. In total, 5 patients were managed with percutaneous nephrostomy, and 15 patients with retrograde ureteral stenting. All symptomatic patients responded to urinary diversion. The overall median survival was 5.8 months, and the 6-month and 1-year survival rates were 48 and 32%, respectively. Chemotherapy was found to be the only independent predictor of survival (p = 0.0498). Median survival in patients who received chemotherapy was 11.2 months, in comparison to 3.1 months in patients who did not receive chemotherapy (p = 0.0002).

Conclusions

The prognosis of ureteral obstruction secondary to gastric cancer was extremely poor, particularly when chemotherapy was not administered. The indications for palliative urinary diversion should be determined after considering the patient’s symptoms, the expected survival time, the possibility of further chemotherapeutic options, and the current quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Chung SY, Stein RJ, Landsittel D et al (2004) 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 172:592–595

    Article  PubMed  Google Scholar 

  2. Jeong IG, Han KS, Joung JY et al (2007) The outcome with ureteric stents for managing non-urological malignant ureteric obstruction. BJU Int 100:1288–1291

    Article  PubMed  Google Scholar 

  3. Tanaka T, Yanase M, Takatsuka K (2004) Clinical course in patients with percutaneous nephrostomy for hydronephrosis associated with advanced cancer. Hinyokika Kiyo 50:457–462

    PubMed  Google Scholar 

  4. Ishioka J, Kageyama Y, Inoue M et al (2008) Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. J Urol 180:618–621

    Article  PubMed  Google Scholar 

  5. Donat SM, Russo P (1996) Ureteral decompression in advanced nonurologic malignancies. Ann Surg Oncol 3:393–399

    Article  PubMed  CAS  Google Scholar 

  6. Chitale SV, Scott-Barrett S, Ho ET et al (2002) The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 57:1118–1121

    Article  PubMed  CAS  Google Scholar 

  7. Wilson JR, Urwin GH, Stower MJ (2005) The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl 87:21–24

    Article  PubMed  CAS  Google Scholar 

  8. Wong LM, Cleeve LK, Milner AD et al (2007) Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol 178:178–183

    Article  PubMed  Google Scholar 

  9. Ku JH, Lee SW, Jeon HG et al (2004) Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology 64:895–899

    Article  PubMed  Google Scholar 

  10. Liaw CC, Chuang CK, Chen JS et al (1997) Gastric cancer with obstructive uropathy: clinical experience with 17 cases. Changgeng Yi Xue Za Zhi 20:286–292

    PubMed  CAS  Google Scholar 

  11. Roviello F, Marrelli D, de Manzoni G et al (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1119

    Article  PubMed  CAS  Google Scholar 

  12. Osugi H, Takada N, Takemura M et al (2002) Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination. Oncol Rep 9:811–815

    PubMed  CAS  Google Scholar 

  13. Yamao T, Shimada Y, Shirao K et al (2004) Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Jpn J Clin Oncol 34:316–322

    Article  PubMed  Google Scholar 

  14. Joshi HB, Adams S, Obadeyi OO et al (2001) Nephrostomy tube or “JJ” ureteric stent in ureteric obstruction: assessment of patient perspectives using quality-of-life survey and utility analysis. Eur Urol 39:695–701

    Article  PubMed  CAS  Google Scholar 

  15. Radecka E, Magnusson A (2004) Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol 45:184–188

    Article  PubMed  CAS  Google Scholar 

  16. Romero FR, Broglio M, Pires SR et al (2005) Indications for percutaneous nephrostomy in patients with obstructive uropathy due to malignant urogenital neoplasias. Int Braz J Urol 31:117–124

    Article  PubMed  Google Scholar 

  17. Tamura S, Miki H, Nakata K et al (2007) Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. Gastric Cancer 10:251–255

    Article  PubMed  CAS  Google Scholar 

  18. Harrington KJ, Pandha HS, Kelly SA et al (1995) Palliation of obstructive nephropathy due to malignancy. Br J Urol 76:101–107

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Nara Prefectural Nara Hospital, 1-30-1 Hiramatsu, Nara, 631-0846, Japan

    Kazuhiro Migita, Akihiko Watanabe, Takao Ohyama & Hirofumi Ishikawa

  2. Department of Urology, Nara Prefectural Nara Hospital, 1-30-1 Hiramatsu, Nara, 631-0846, Japan

    Shoji Samma & Yoriaki Kagebayashi

Authors
  1. Kazuhiro Migita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiko Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shoji Samma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takao Ohyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirofumi Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoriaki Kagebayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiro Migita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migita, K., Watanabe, A., Samma, S. et al. Clinical Outcome and Management of Ureteral Obstruction Secondary to Gastric Cancer. World J Surg 35, 1035–1041 (2011). https://doi.org/10.1007/s00268-011-1016-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1016-8

Keywords

Search

Navigation